|
 |
|
Practice Areas
The Meneo Law Group's experienced attorneys fight hard for victims of defective pharmaceutical or medical products. Representing clients nationwide, our practice areas include Ketek®, SSRIs®, Zyvox®, Ortho Evra® and Guidant litigation.
 |
Ketek®
Ketek® (telithromycin), a recently approved antibiotic, has been associated with an increased risk of liver failure. On January 20, 2006, the U.S. Food and Drug Administration (FDA) issued a Public Health Advisory in which the FDA warned about the use of Ketek® and potential liver toxicity.
|
|
SSRIs®
A recently published study that appeared in the New England Journal of Medicine indicates that the use of anti-depressant medications know as Selective Serotonin Reuptake Inhibitors (SSRIs) during the latter half of pregnancy may increase the risk that the newborn will develop a serious respiratory disorder known as Persistent Pulmonary Hypertension (PPHN). These anti-depressants include: Prozac, Paxil, Zoloft, Wellbutrin, Celexa, Cipralex, Luvox, Remeron and Effexor.
|
|
Zyvox®
A recent article that appeared in the medical journal Neurology reported three cases of optic and peripheral neuropathy associated with the use of Zyvox® (Linezolid) an antibiotic designed to treat certain bacterial infections.
|
|
Ortho Evra®
On November 10, 2005 the FDA announced that the labeling for the Ortho Evra birth control patch was changed to include "a new bolded warning about the higher exposure to estrogen for women using the weekly patch compared to taking a daily birth control pill...Higher levels of estrogen may put some women at increased risk for getting blood clots." Blood clots can result in a heart attack, stroke or pulmonary embolism requiring immediate and extensive medical care.
|
|
Guidant
Guidant, Corp., a manufacturer of medical devices including Implantable Cardioverter Defibrillators ("ICD"s) and Cardiac Resynchronization Therapy defibrillators ("CRT"s), has recently announced two separate recalls of its defibrillator devices. The total recall involves some 96,000 defibrillators. Guidant has also issued warnings and recalls about a number of its pacemaker devices.
|
|
 |
|
